InvestorsHub Logo
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

Re: califax post# 2742

Sunday, 04/18/2010 6:50:52 AM

Sunday, April 18, 2010 6:50:52 AM

Post# of 30377
...will jointly present data at the 101st Annual Meeting of the American Association for Cancer Research (AACR), in Washington, D.C. from April 17-21, 2010. The poster presentation, entitled, “Å6 peptide binds to CD44 and inhibits migration and metastasis of CD44+ cell lines in in vitro and in vivo studies,” covers pre-clinical work completed by Bio-Quant on Ångstrom’s lead product, Å6, currently in Phase 2 development for ovarian cancer.

NexMed and Ångstrom Pharmaceuticals to Present Data on Å6 Drug at AACR
Tuesday April 13, 2010, 11:00 am EDT
http://finance.yahoo.com/news/NexMed-and-ngstrom-bw-3991454208.html?x=0&.v=1

posts are IMHO // either news - with LINK

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News